ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

51
Analysis
Health CareNew Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
Refresh
bearishPacific Edge
15 Jul 2023 20:00Broker

Pacific Edge (PEB): LCD Update – Signs of Life

The implementation of LCD, L35396 “Genetic Testing for Oncology” that would have resulted in Pacific Edge’s (PEB) CMS reimbursement ceasing on 17...

Logo
345 Views
Share
bullishPacific Edge
17 Jun 2023 20:00Broker

Pacific Edge: CMiSery

Pacific Edge's (PEB) CMS reimbursement will cease effective 17 July 2023. Materiality is very high — our prior base case assumed CMS would...

Logo
362 Views
Share
bearishPacific Edge
17 Jun 2023 20:00Broker

Pacific Edge (PEB): Medicare Response − Bad News Confirmed

Pacific Edge (PEB) has confirmed the finalisation of Novitas' Local Coverage Determination (LCD); Its response to the market this morning dit not...

Logo
365 Views
Share
bearishPacific Edge
14 Jun 2023 20:00Broker

Pacific Edge: Final LCD Decision — Not Good News

Novitas has issued its finalised Local Coverage Determination (LCD) which means Pacific Edge (PEB’s) Cxbladder tests at this stage will not be...

Logo
279 Views
Share
bullishPacific Edge
14 Jun 2023 20:00Broker

Pacific Edge (PEB): LCD Finalisation – Not Good News

The much anticipated Local Coverage Determination (LCD) decision has been made in the past 24 hours; Consistent with the proposal, PEB’s Cxbladder...

Logo
278 Views
Share
x